Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
EV/EBITDA | ? | -1.57 | -11.2 | -0.09 | 0.32 | -0.20 | -0.11 | |
Changes by years, y/y, % | -127% | +616% | -99% | -447% | -164% |
Black Diamond Therapeutics. EV/EBITDA
Black Diamond Therapeutics. EV/EBITDA, changes, %
Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EV/EBITDA | ? | -0.31 | -0.45 | -2.03 | -1.81 | -1.95 | -0.11 | |
Changes by years, y/y, % | -83% | -247% | -2 742% | +31% | +523% | |||
Changes by quarters, q/q, % | -78% | +45% | +348% | -10% | +7% |